Fresenius Medical Care Ventures
Corporate VCBad Homburg · Seed–Late Stage · 8 people tracked
Investment thesis
FMCV makes strategic equity investments in start-ups and early-stage healthcare companies, forming partnerships that give Fresenius Medical Care access to new technologies and therapy approaches in its core and complementary businesses. It invests across multiple healthcare sectors including medical devices, pharmaceuticals, digital healthcare, and healthcare services, from seed to later stage depending on strategic fit. Beyond capital, the firm leverages Fresenius Medical Care's resources to help portfolio companies navigate the path of bringing innovation to patients.
Source: firm website, verified Aug 3, 2026.
Team · 8 people
from the firm's website & public directories
What they invest in
from 10 of 15 portfolio companiesHealthtech ×8Medical Devices ×7Biotech ×5Digital Health ×4AI & Machine Learning ×2Deep Tech ×2Hardware ×2Cybersecurity ×1
HQs:United States×6Germany×1
Investments · 15 tracked
founders shown can be your intro pathHumacyte is a regenerative medicine company that develops a bioengineered, human-derived Acellular Tissue Engineered Vessel (ATEV) along with a scalable cell sourcing and manufacturing platform.
BiotechHealthtechMedical DevicesMorrisville, US
Robert Anderson(Director)Robert Langer(Director)Ted Lithgow(Executive Officer)Laura E. Niklason(Director)Brady W. Dougan(Director)Max Wallace(Director)
Retia Medical develops advanced hemodynamic monitoring devices, including the Argos Cardiac Output Monitor, which uses proprietary algorithms to provide real-time clinical decision support for high-risk patients.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Marc Zemel(Co-Founder and CEO)Jerry Korten(Executive Vice President)Roger Mecca(Consultative Medical Officer)Alexander Markovic(Chief Operating Officer)Ramakrishna Mukkamala(Co-Founder)
Albutec develops extracorporeal albumin dialysis (ECAD) technology, including its MaxiCycler device with redesigned adsorbent and tubing, to support or replace liver function in patients with acute and acute-on-chronic liver failure.
BiotechHardwareHealthtechMedical DevicesRostock, DE
Katrin Stange(Chief Executive Officer)Jan Stange(Chief Medical Officer)
BioIntelliSense develops scalable physiologic monitoring technology for continuous, proactive patient monitoring aimed at improving clinical outcomes and lowering the cost of care.
Digital HealthHealthtechIoTMedical DevicesGolden, US
Conlan Ma(Director)David Wang(Executive Officer, Director)Xinyaun Yu(Director)James Mault(Executive Officer, Director)Ronald Chwang(Director)Alan Meeker(Director)
eGenesis uses gene editing and genome engineering to develop porcine donor animals for cross-species organ transplantation, addressing organ failure treatment and transplant supply constraints.
BiotechDeep TechMedical Devices
Mike Curtis, Ph.D.(President & Chief Executive Officer)
BiotechHealthtechMartinez, US
Michael DiMeo(Executive Officer)Erin Borger(Executive Officer, Director)Robert S. Ward(Executive Officer, Director)Keith McCrea(Executive Officer, Director)Eber Jaques(Director)George Pitarra(Executive Officer, Director)
Stimdia Medical develops neuromodulation technologies, with a leadership team focused on clinical and regulatory affairs and R&D in critical care and pulmonary medicine.
BiotechDeep TechHealthtechMedical DevicesEdina, US
James Bullock(Director)Jay Katarincic(Founder, Stimdia Medical; Director, Draper Triangle Ventures)Patrick Wethington(Executive Officer, Director)Allen Meacham(President and Chief Executive Officer)Brad Swatfager(Chief Financial Officer)Kristen Lechleiter(Vice President, Clinical and Regulatory Affairs)
Synack provides penetration testing and security assessments for enterprise security teams, combining AI agents with human testers to evaluate complex attack surfaces and protect critical infrastructure.
AI & Machine LearningCybersecurityEnterprise SoftwareRedwood City, US
Ted Schlein(Director)Derek W. Smith(Director)Mark Kuhr(Director)Jay Kaplan(Executive Officer, Director)
BoardGlenn Solomon(Director)Tom Mawhinney(Director)
Vectorious Medical Technologies develops implantable sensing platforms designed to deliver clinical information for patient therapies.
Digital HealthHardwareHealthtechMedical Devices
Exits · 2
IPOs and acquisitions across the tracked portfolioPortfolio news
latest coverage across their companiesSynack · markets.businessinsider.com · Jun 9, 2026
Frequently asked questions
- What stage does Fresenius Medical Care Ventures invest at?
- Fresenius Medical Care Ventures invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What sectors does Fresenius Medical Care Ventures focus on?
- Fresenius Medical Care Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Fresenius Medical Care Ventures located?
- Fresenius Medical Care Ventures is headquartered in Bad Homburg, DE.
Media · Podcasts & interviews
from their channelArtful Resilience: Samroeng Getlim's Story | Life on Dialysis – FME Asia Pacific
Fresenius Medical Care
The confidence to live fully: Chan Kok Wah's Story | Life on dialysis - FME Asia Pacific
Fresenius Medical Care
Freedom in my hands: Anitha Raju's Story | Life on dialysis - FME Asia Pacific
Fresenius Medical Care
A new beginning, a future awaiting: Fatin Adibah’s Story | Life on Dialysis – FME Asia Pacific
Fresenius Medical Care
Thriving Against All Odds: Yvonne Khoo's Story | FME Asia Pacific
Fresenius Medical Care
Streaming en vivo grabado - 2° Summit HighvolumeHDF - Tarde
Fresenius Medical Care
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
Capricorn Venture Partners is a European investment firm managing several thematic funds across growth capital, healthcare, and cleantech, as well as a combined private/quoted investment vehicle.
The Novartis Venture Fund invests in innovative life science companies, focusing on biotechnology and biopharmaceuticals at various stages of growth, aiming to drive patient benefit and generate returns.
EQT Life Sciences, formerly LSP, is one of Europe's largest and most experienced life sciences investors, backing companies developing therapeutics, medical devices, diagnostics and healthtech globally. It is part of EQT Group.
Portfolia operates thematic venture capital funds designed for women investors, backing companies in areas such as women's health, longevity, active aging, greentech, and fintech, while offering an educational and community-driven investing experience.